CNR1 and peripheral neuropathy: These findings expand upon previous reports, showing that AM1710’s peripheral anti‐allodynic effects in a chemotherapy‐induced peripheral neuropathy mouse model are not due to CB1R‐related mechanisms (Deng et al., 2012, 2015).